Symbol | YTM % | Wolumen | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
---|---|---|---|---|---|---|---|---|---|
TTEVA.GJTeva Pharmaceutical Finance Co. LLC 0.25% 01-FEB-2026 | 7,69% | 18 K | 93,02% | 0,25% | 2026-02-01 | 22,88 M USD | 1 000,00 USD | 1 000,00 USD | Teva Pharmaceutical Finance Co. LLC |
TTFACTEVA P.FI.NL III 16/46 | 7,34% | 0 | 72,90% | 4,10% | 2046-10-01 | 2 B USD | 1 000,00 USD | 2 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
TTEVA4608603Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 6,96% | 1 M | 99,25% | 6,75% | 2028-03-01 | 255 K USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
UUS88163VAD1TEVA PHARM.FIN. 2036 | 6,08% | 0 | 100,43% | 6,15% | 2036-02-01 | 789,43 M USD | 1 000,00 USD | 2 000,00 USD | Teva Pharmaceutical Finance Co. LLC |
TTEVA5549924Teva Pharmaceutical Finance Netherlands III BV 8.125% 15-SEP-2031 | 5,73% | 2,82 M | 111,50% | 8,13% | 2031-09-15 | 500 M USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
TTFABTEVA P.FI.NL III 16/26 | 5,61% | 0 | 96,29% | 3,15% | 2026-10-01 | 3,38 B USD | 1 000,00 USD | 2 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
TTEVA5295245Teva Pharmaceutical Finance Netherlands III BV 5.125% 09-MAY-2029 | 5,60% | 1,64 M | 98,36% | 5,13% | 2029-05-09 | 1 B USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
TTEVA5549923Teva Pharmaceutical Finance Netherlands III BV 7.875% 15-SEP-2029 | 5,59% | 1,71 M | 108,36% | 7,88% | 2029-09-15 | 600 M USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
TTEVA4608604Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 5,54% | 1,64 M | 103,17% | 6,75% | 2028-03-01 | 1,25 B USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
TTEVA5295244Teva Pharmaceutical Finance Netherlands III BV 4.75% 09-MAY-2027 | 4,90% | 872 K | 99,70% | 4,75% | 2027-05-09 | 1 B USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
XXS181372460TEVA PH.F.NL.II 18/25 | 4,50% | 0 | 100,00% | 4,50% | 2025-03-01 | 494,35 M EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
XXS240660717TEV.P.F.N.II 21/30 | 3,82% | 0 | 102,45% | 4,38% | 2030-05-09 | 1,5 B EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
XXS259280419TEV.P.F.N.II 23/31 | 3,81% | 0 | 121,48% | 7,88% | 2031-09-15 | 500 M EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
XXS259280443TEV.P.F.N.II 23/29 | 3,73% | 0 | 114,34% | 7,38% | 2029-09-15 | 800 M EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
XXS240660709TEV.P.F.N.II 21/27 | 3,64% | 0 | 100,22% | 3,75% | 2027-05-09 | 1,1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
XXS121104407TEVA PH.F.NL.II 15/27 | 3,59% | 0 | 96,58% | 1,88% | 2027-03-31 | 700 M EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
XXS143974936TEVA PH.F.NL.II 16/28 | 3,47% | 0 | 93,96% | 1,63% | 2028-10-15 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
CCH33382750TEVA PH.FI.NL IV 16-25 | 1,75% | 0 | 99,65% | 1,00% | 2025-07-28 | 350 M CHF | 5 000,00 CHF | 5 000,00 CHF | Teva Pharmaceutical Finance Netherlands IV BV |